Coya Therapeutics (COYA) Return on Capital Employed Growth (3y) (2026)

Coya Therapeutics (COYA) Return on Capital Employed Growth (3y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn - -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -
4 BeOne Medicines 472.68 Bn 467.89 Bn 1.35 Bn 4,893.00
5 Vertex Pharmaceuticals 122.24 Bn 114.99 Bn 2.59 Bn -494.00
6 Regeneron Pharmaceuticals 70.08 Bn 61.33 Bn 3.31 Bn -649.00
7 Belite Bio 62.46 Bn 62.46 Bn - -
8 Argenx Se 55.93 Bn 50.75 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.59 Bn 34.58 Bn 959.66 Mn 4,853.00
10 Coya Therapeutics 98.05 Mn 47.33 Mn - 4,775.00

Historic Data

Download Data
DateValue
Mar 31, 2026 4,775.00